Atlas Trials

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer

Clinical trial NCT07659795 · RECRUITING

Trial details

NCT number
NCT07659795
Sponsor
Verastem, Inc.
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Colorectal Cancer
Start date
2026-07-28
Primary completion
2027-06-01
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.